| Q47547047 | Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment |
| Q50050843 | An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages. |
| Q37264020 | Behavioral and neurophysiological hallmarks of simian immunodeficiency virus infection in macaque monkeys |
| Q37015474 | Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders |
| Q34729961 | CANTAB delayed matching to sample task performance in juvenile baboons. |
| Q34732834 | COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection |
| Q46620454 | Consistent, high-level ethanol consumption in pig-tailed macaques via a multiple-session, limited-intake, oral self-dosing procedure |
| Q37122421 | Contributions of non-human primates to neuroscience research |
| Q24810353 | Development and characterization of positively selected brain-adapted SIV. |
| Q36176714 | Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys. |
| Q61443126 | Disruption of Timing: NeuroHIV Progression in the Post-cART Era |
| Q37094265 | Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques |
| Q42484653 | Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation |
| Q36844753 | Effects of Morphine on Behavioral Task Performance in SIV-Infected Rhesus Macaques |
| Q36002666 | Effects of simian immunodeficiency virus on the circadian rhythms of body temperature and gross locomotor activity |
| Q33882450 | HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment. |
| Q40066321 | HIV-associated synaptic degeneration |
| Q45417303 | Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. |
| Q37265519 | Large animal models of neurological disorders for gene therapy |
| Q35673192 | Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons |
| Q28539980 | Optimization of touchscreen-based behavioral paradigms in mice: implications for building a battery of tasks taxing learning and memory functions |
| Q97524620 | Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders |
| Q30452156 | Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials |
| Q38306931 | Rhesus monkeys employ a procedural strategy to reduce working memory load in a self-ordered spatial search task |
| Q36302059 | Rodent model systems for studies of HIV-1 associated dementia |
| Q35242182 | SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation |
| Q33893665 | Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA |
| Q35119113 | Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus |
| Q46276062 | Touchscreen technology in the study of cognition-related behavior |
| Q37264013 | Virus-host interaction in the simian immunodeficiency virus-infected brain |
| Q33292132 | p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. |